Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Biomea Fusion, Inc. (NASDAQ: BMEA) had its price target raised by analysts at JPMorgan Chase & Co. from $14.00 to $15.00. They now have a "neutral" rating on the stock.
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights [Yahoo! Finance]
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)